Back
Standard BioTools Quote, Financials, Valuation and Earnings
Sponsored
LAB
Sponsored
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Buy
63
LAB
Standard BioTools
Last Price:
2.11
Seasonality Move:
18.86%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!Standard BioTools Price Quote
$2.11
Standard BioTools Key Stats
Buy
63
Standard BioTools (LAB)
is a Buy
Day range:
$2.06 - $2.23
52-week range:
$1.21 - $3.04
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.78
P/B ratio:
1.6%
Volume:
3.6M
Avg. volume:
1.7M
1-year change:
0.96%
Market cap:
$783.1M
Revenue:
$106.3M
EPS:
$-0.71
How Much Does Standard BioTools Make?
-
How Much Are Standard BioTools's Sales Annually?
LAB Revenues are $106.3M -
How Much Profit Does Standard BioTools's Make A Year?
LAB net income is -$74.7M
Is Standard BioTools Growing As A Company?
-
What Is Standard BioTools's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.77% -
What Is Standard BioTools's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Standard BioTools Stock Price Performance
-
Did Standard BioTools Stock Go Up Last Month?
Standard BioTools share price went up by 14.05% last month -
Did LAB's Share Price Rise Over The Last Year?
LAB share price rose by 0.96% over the past 1 year
What Is Standard BioTools 52-Week High & Low?
-
What Is Standard BioTools’s 52-Week High Share Price?
Standard BioTools has traded as high as $3.04 over the past 52 weeks -
What Is Standard BioTools’s 52-Week Low Share Price?
Standard BioTools has traded as low as $1.21 over the past 52 weeks
Standard BioTools Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Standard BioTools?
-
How Much Debt Does Standard BioTools Have?
Total long term debt quarterly is $55.2M -
How Much Cash Does Standard BioTools Have?
Cash and short term investments quarterly total is $366.3M -
What Is Standard BioTools’s Book Value Per Share?
Book value per share is 1.32
Is Standard BioTools Cash Flow Positive?
-
What Is LAB Cash Flow From Operations?
Cash flow from operations (TTM) is -$143.5M -
What Is Standard BioTools’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$49.1M -
What Is Standard BioTools’s Cash Flow From Investing?
Cash flow from investing (TTM) is $324.3M
Standard BioTools Return On Invested Capital
-
Is Management Doing A Good Job?
LAB return on invested capital is -39.17% -
What Is Standard BioTools Return On Assets?
ROA measures how assets are converting to revenues and is -22.01% -
What Is LAB Return On Equity?
ROE is a measure of profitability and is -48.03%
Standard BioTools Earnings Date & Stock Price
-
What Is Standard BioTools's Stock Price Today?
A single share of LAB can be purchased today for 2.11 -
What Is Standard BioTools’s Stock Symbol?
Standard BioTools trades on the nasdaq under the ticker symbol: LAB -
When Is Standard BioTools’s Next Earnings Date?
The next quarterly earnings date for Standard BioTools is scheduled on February 28, 2025 -
When Is LAB's next ex-dividend date?
Standard BioTools's next ex-dividend date is November 6, 2024 -
How To Buy Standard BioTools Stock?
You can buy Standard BioTools shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Standard BioTools Competitors
-
Who Are Standard BioTools's Competitors?
Below is a list of companies who compete with Standard BioTools or are related in some way:
Standard BioTools Dividend Yield
-
What Is LAB Dividend Yield?
Standard BioTools’s dividend yield currently is 0% -
What Is Standard BioTools’s Payout Ratio?
Standard BioTools’s payout ratio is 0% -
When Did Standard BioTools Last Pay A Dividend?
The latest dividend pay date is November 6, 2024 -
What Is Standard BioTools’s Dividend Per Share?
Standard BioTools pays a dividend of $0.00 per share
Standard BioTools Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 53.87% |
Revenue: | 77.27% | 9.68% |
Analyst Recommendations
Buy Recommendations: | 3 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 3.08 |
Upside from Last Price: | 46.13% |